HCPCS Code Descriptor:
Injection, trimethobenzamide hcl, up to 200 mg
Route of Administration:
TIGAN is an Oncology-Anti-Emetic drug manufactured by Par Pharmaceuticals and administered via the Intramuscular route of administration. The J Code: J3250 is aligned to the drug TIGAN.